The healthtech industry is experiencing intense competition as companies race to develop software and artificial intelligence (AI) tools for clinical decision support, medical telemetry, robotic surgery, surgical navigation, medical imaging
Continue Reading Building a Future-Proof IP Strategy for AI in Medtech
AI has continued to come under the scrutiny of government enforcers and private litigants. In July 2025, the White House released America’s AI Action Plan. As we noted in our
Continue Reading AI Antitrust Landscape 2025: Federal Policy, Algorithm Cases, and Regulatory ScrutinyWhile the EB-5 visa has proven popular with a number of Israeli investors who have obtained a green card using the EB-5 program, options U.S. immigration visas for Israeli entrepreneurs
Continue Reading USCIS Proposes International Entrepreneur Rule to Spur Innovation and Job Creation
On June 6, the Boston office of Greenberg Traurig hosted the Wharton Israel Conference “Spotlight on Israeli Innovation in Healthcare and Biopharmaceuticals” for Boston area biotechnology and pharmaceutical professionals with
Continue Reading Greenberg Traurig Hosts Wharton Israel Conference Monday, June 6, 2016